Diagnosis, Classification and Treatment of Heart Failure in Older Adults

Join this Webinar as the faculty provide insights into the challenges of managing older adults with HF. Key topics include:

  • Diagnosis of HF including the signs, symptoms, and recommended diagnostic testing tools 
  • Enhancing your ability to define staging based on ACCF/AHA staging guidelines; and determine whether the patient has preserved or reduced EF
  • Developing an individualized management plan for the older adult patient with HF using pharmacotherapy complemented with nonpharmacologic interventions

Agenda

Program length (60 minutes)

  • Welcome and Introduction
  • Panel Discussion with Patient Voice
  • Discussion and Audience Question and Answer Session

Events

Date / Time
Event Details

Faculty

Program Director
Gregg C. Fonarow, MD

Director, Ahmanson-UCLA Cardiomyopathy Center
Co-Director, UCLA Preventative Cardiology Program
Co-Chief, UCLA Division of Cardiology
The Eliot Corday Chair in Cardiovascular Medicine and Science
Los Angeles, California

Faculty
Margaret Bowers, DNP, FNP-BC

Associate Professor
Duke University School of Nursing
Durham, North Carolina

Faculty
Elizabeth Pogge, PharmD

Professor 
Department of Pharmacy Practice
College of Pharmacy-Glendale
Midwestern University
Glendale, Arizona

Goal Statement
The goal of this initiative is to increase knowledge and competence among primary care physicians, gerontological advanced practice nurses, other clinicians, and senior care pharmacists in the diagnosis and management of HF in older adults.

Target Audience
This activity is intended for primary care physicians, advanced practice nurses, physician assistants, and consultant or senior care pharmacists who care for older adults.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Recognize the signs and symptoms of HF in older adult patients.
  • Select appropriate testing to confirm the diagnosis of HF in older adult patients.
  • Stage and classify (HFrEF vs. HFpEF) a patient’s HF based on their clinical presentation, current guidelines, and diagnostic testing.
  • Describe treatment options, including newly available agents, and consider factors relevant to pharmacotherapy selection for older adult patients with HF.
  • Develop an individualized management strategy for an older adult patient with HF incorporating both pharmacologic and nonpharmacologic interventions.

Accreditation

Accreditation

The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation:

The University of Cincinnati designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*The American Academy of Physician Assistants, the American Association of Nurse Practitioners and the American Nurses Credentialing Center accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

 

Nursing Continuing Education

This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) ,  the Gerontological Advanced Practice Nurses Association (GAPNA), and Clinical Care Options.

Anthony J. Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.

A maximum of 1.0 contact hour, which includes 30 minutes of pharmacology content, may be earned by learners who successfully complete this continuing nursing education activity.

 

Continuing Pharmacy Education (CPE)

The American Society of Consultant Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ASCP designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: 0203-9999-20-040-L01-P

Type of Activity: Application

You must participate in this activity in its entirety and complete the evaluation form to receive CPE credit. Partial credit will not be granted. The course should be posted to CPE Monitor within 60 days of evaluation completion.

Disclosure of Conflicts of Interest
University of Cincinnati requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Unviersity’s policy. University of Cincinnati is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.